Feedback / Questions
Rinvoq (upadacitinib) - AbbVie
Rinvoq: Newly added patent in Orange Book
(Orange Book)
-
Apr 22, 2020 -
Expiry on October 17, 2036
Patent
•
Ankylosing Spondylitis • Atopic Dermatitis • Dermatitis • Immunology • Inflammation • Inflammatory Bowel Disease
https://www.accessdata.fda.gov/scripts/cder/ob/search_patent.cfm?listed=new
Apr 22, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious